Brain tumors: an update on clinical PET research in gliomas
K Herholz - Seminars in nuclear medicine, 2017 - Elsevier
A previous review published in 2012 demonstrated the role of clinical PET for diagnosis and
management of brain tumors using mainly FDG, amino acid tracers, and 18 F-
fluorothymidine. This review provides an update on clinical PET studies, most of which are
motivated by prediction of prognosis and planning and monitoring of therapy in gliomas. For
FDG, there has been additional evidence supporting late scanning, and combination with 13
N ammonia has yielded some promising results. Large neutral amino acid tracers have …
management of brain tumors using mainly FDG, amino acid tracers, and 18 F-
fluorothymidine. This review provides an update on clinical PET studies, most of which are
motivated by prediction of prognosis and planning and monitoring of therapy in gliomas. For
FDG, there has been additional evidence supporting late scanning, and combination with 13
N ammonia has yielded some promising results. Large neutral amino acid tracers have …
